Vincent A. Forlenza, CEO of Becton Dickinson (BD), has been appointed chairman of the board. Forlenza has been with the Franklin Lakes, N.J-based medical technology company since 1980, and has served as CEO since October of last year. He succeeds Edward J. Ludwig as chairman, who is retiring from BD. Forlenza will take on his additional duties on July 1.
Prior to CEO, Forlenza served as chief operating officer since July 2010. He also has occupied the roles of president, executive vice president, president of BD Biosciences, and senior vice president of technology, strategy and development in reverse chronological order. During his long tenure at BD, he has served in positions of increasing responsibility both in the United States and Europe. He also has served as the chairman and director of AdvaMed Dx, a division of AdvaMed that focuses on diagnostics, since October 2010. He is chairman of the Valley Hospital Board of Trustees at Valley Health Systems and is a member of the advisory board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University in Bethlehem, Pa. Forlenza holds a bachelor’s degree in Chemical Engineering from Lehigh University and an MBA from the Wharton School of the University of Pennsylvania.
"Vince has demonstrated strong leadership and strategic vision during his time as CEO, and he has a deep understanding of BD, the medical technology industry and the global healthcare environment. We are confident that he is the right person to chair our board," said Henry P. Becton Jr., BD's lead director.